What Is My Behavioral Health Business Worth in 2026?

Behavioral health businesses are selling for 5.0x-10.0x EBITDA in 2026, with strong platform assets commanding 10x-13x EBITDA multiples. Smaller practices under $10M revenue typically trade in the 3x-8x EBITDA range, while mid-sized operations with diversified payor mix, in-network contracts, and scalable clinical infrastructure are commanding 6x-10x EBITDA. Active buyers include LifeStance Health, Acadia Healthcare, Behavioral Health Group, Discovery Behavioral Health, Clearview Capital, and dozens of private equity add-on platforms.

Who this is for: Owners of outpatient mental health groups, SUD and addiction treatment facilities, ABA therapy practices, intensive outpatient programs, and partial hospitalization programs generating at least $500K in EBITDA who are thinking about selling in the next 12-24 months.

How Is a Behavioral Health Business Valued?

Valuation comes down to EBITDA, multiple, and working capital adjustments — but the nuances matter more here than in almost any other industry I work in. Buyers apply a multiple to trailing twelve-month adjusted EBITDA, then adjust for working capital, closing expenses, and any deferred revenue obligations. The recast of EBITDA is where most of the negotiation happens: owner compensation, one-time consulting fees, non-recurring litigation, and excess rent paid to a related-party landlord all come out. In my experience, a clean recast typically adds 15-30% to stated EBITDA for owner-operated practices.

What makes behavioral health unique is the layer of scrutiny on revenue quality. Buyers don't just look at total collections — they look at payor mix, reimbursement trends, credentialing status of each clinician, and the defensibility of billing practices. A practice with 70% in-network commercial contracts and documented outcomes will command a meaningfully higher multiple than a practice with the same EBITDA running primarily cash-pay or out-of-network billing.

What Are Current Behavioral Health Valuation Multiples?

In 2026, the market has bifurcated. Platform-quality assets with $5M+ in EBITDA, diversified payor mix, strong clinical leadership, and scalable infrastructure are trading at 10x-13x EBITDA. Mid-market practices in the $1M-$5M EBITDA range are typically achieving 6x-10x. Smaller single-location practices under $1M EBITDA are selling in the 3x-6x range, usually to strategic buyers looking for geographic tuck-ins.

By sub-sector, ABA therapy practices are trading at 6x-8x EBITDA with commercial contracts adding premium value. Out-of-network substance use disorder providers are in the 4x-6x range. In-network SUD and mental health groups are achieving 6x+ with the strongest platforms reaching double-digit multiples. Psychiatric practices with medication management and therapy capabilities are highly sought after, especially those with telehealth infrastructure and multi-state licensure.

Who's Buying Behavioral Health Businesses in 2026?

The buyer pool is deeper than it's ever been. On the strategic side, LifeStance Health has publicly stated they're prioritizing smaller tuck-in acquisitions for geographic expansion. Acadia Healthcare remains a major buyer of inpatient and residential assets. Behavioral Health Group (BHG) is consolidating the opioid treatment program space. Discovery Behavioral Health, Odyssey Behavioral Healthcare, and Universal Health Services round out the strategic acquirers.

On the private equity side, the volume is enormous. Clearview Capital, Bain Capital, TPG, Webster Equity Partners, and Nautic Partners all have active behavioral health platforms. Add-on activity grew 19% year-over-year in 2025, while strategic deal volume was up 105%. The CMS behavioral health access rule finalized in 2024, combined with mental health parity enforcement, has locked in demand for the sector for the rest of this decade. I regularly see behavioral health practices with any kind of platform characteristics draw multiple buyer offers in the same diligence window.

What Makes a Behavioral Health Business Worth More?

Multiple expansion in behavioral health comes from a short list of factors. First, payor mix — in-network commercial contracts with Aetna, BCBS, Cigna, UHC, and Optum command a premium because they signal durable reimbursement. Second, clinician retention and leverage — practices where non-owner clinicians generate the majority of billable revenue scale more cleanly for a buyer. Third, multi-service capability — groups that can deliver medication management, therapy, group programming, and IOP/PHP under one roof are more valuable than single-service providers. Fourth, clean compliance — HIPAA, documentation of medical necessity, clinician credentialing, and state licensure all need to be bulletproof. Fifth, telehealth infrastructure and multi-state licensure — buyers pay for scalability.

Other factors that drive premium pricing include a strong EHR with clean data export, measurable clinical outcomes (PHQ-9 and GAD-7 tracking is table stakes now), and a referral base that isn't concentrated with one or two sources. Businesses with strong outcomes data and diversified payor and referral mix increasingly attract interest from adjacent healthcare acquirers building integrated care platforms.

What Hurts Behavioral Health Valuations?

Several things drag multiples down quickly. Heavy reliance on Medicaid-only contracts without a strategy for commercial or private pay creates reimbursement risk, especially with state budget uncertainty. Owner-clinician dependency is a major discount — if the founder generates more than 35% of clinical revenue, buyers will either walk or structure a substantial earnout. Poor documentation of medical necessity and weak HIPAA compliance raise audit risk and scare off sophisticated buyers.

High clinician turnover, unclear credentialing status, and any history of payor audits or takebacks also reduce value. Out-of-network billing practices, once a premium play, now face discounting as buyers worry about reimbursement compression and network adequacy enforcement. Finally, underinvestment in EHR and revenue cycle management — paper charts, outsourced billing with no reporting, no KPIs — tells buyers they'll need to invest significantly post-close, and they'll price that in.

How Long Does It Take to Sell a Behavioral Health Business?

The typical timeline runs 6-12 months from engagement to close. The first 4-6 weeks go to preparation — recasting financials, pulling payor mix reports, organizing credentialing files, and building the confidential information memorandum. Marketing and buyer outreach runs 6-10 weeks. Letters of intent and exclusivity typically take another 2-4 weeks to negotiate. Due diligence is the long phase — 60-90 days for behavioral health given the payor, compliance, and clinical scrutiny involved. Documentation and close run another 30-45 days.

"Behavioral health is the most buyer-rich sector I work in right now, but it's also the most diligence-heavy. I had a practice last year in the $2.5M EBITDA range that ran a competitive process with seven LOIs, then took another four months to close because the buyer's compliance counsel wanted to verify every clinician credentialing file going back three years. Owners who haven't cleaned up their documentation learn in diligence what that costs them — sometimes a multiple turn, sometimes the whole deal. The owners who prepare early get paid."

— John M. Salony, Business Broker